Dr. Goldsweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8200 Dodge St
Omaha, NE 68114Phone+1 402-955-4140Fax+1 402-955-4100- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterFellowship, Pediatric Endocrinology, 2013 - 2016
- NYU Grossman School of MedicineResidency, Pediatrics, 2007 - 2010
- New York University School of MedicineClass of 2007
Certifications & Licensure
- MA State Medical License 2016 - 2025
- NE State Medical License 2017 - 2024
- RI State Medical License 2016 - 2018
- CT State Medical License 2010 - 2016
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Measurement of Beta Cell Death in Individuals With Cystic Fibrosis Start of enrollment: 2019 Apr 04
Publications & Presentations
PubMed
- Regression from stage 3 to stage 2 type 1 diabetes mellitus after discontinuing growth hormone therapy.Micah A Fischer, Ghada A Elmahmudi, Bracha K Goldsweig, Salaheddin H Elrokhsi> ;Endocrinology, Diabetes & Metabolism Case Reports. 2023 May 1
- 23 citationsPuberty in cystic fibrosisBracha K. Goldsweig, Beth Kaminski, Aniket Sidhaye, Scott M. Blackman, Andrea Kelly> ;Journal of Cystic Fibrosis. 2019 Oct 1
- 23 citationsCystic fibrosis related diabetes: Nutrition and growth considerations.Beth Kaminski, Bracha K. Goldsweig, Aniket Sidhaye, Scott M. Blackman, Teresa Schindler, Antoinette Moran> ;Journal of Cystic Fibrosis. 2019 Oct 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: